Nov 12, 2024 4:05 pm EST Eyenovia Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Oct 23, 2024 7:00 am EDT Eyenovia Announces Publication of Study Demonstrating Favorable Impact on the Ocular Surface of Medication Delivered with the Optejet®
Oct 16, 2024 7:00 am EDT Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo
Oct 1, 2024 7:00 am EDT Eyenovia Announces Commencement of Manufacturing of its Advanced, Second Generation Optejet Device